Cytokinetics Balance Sheet Health
Financial Health criteria checks 4/6
Cytokinetics has a total shareholder equity of $108.6M and total debt of $655.0M, which brings its debt-to-equity ratio to 603.4%. Its total assets and total liabilities are $1.5B and $1.4B respectively.
Key information
603.4%
Debt to equity ratio
US$654.95m
Debt
| Interest coverage ratio | n/a |
| Cash | US$1.06b |
| Equity | US$108.55m |
| Total liabilities | US$1.42b |
| Total assets | US$1.52b |
Recent financial health updates
Recent updates
Is Cytokinetics (NASDAQ:CYTK) Weighed On By Its Debt Load?
Aug 11
Cytokinetics' Aficamten: Heartfelt Potential Amid Market Woes
Jul 24Cytokinetics Decides To Go It Alone
May 24Here's Why We Think Cytokinetics, Incorporated's (NASDAQ:CYTK) CEO Compensation Looks Fair for the time being
May 09Cytokinetics, Incorporated: Buyout Speculation Persists
Apr 01Cytokinetics: CEO Talks Down Buyout Prospects
Mar 16Cytokinetics Steps Up As Prime Target After Aficamten's HCM Triumph (Rating Upgrade)
Jan 12An Intrinsic Calculation For Cytokinetics, Incorporated (NASDAQ:CYTK) Suggests It's 37% Undervalued
Oct 05Analysts Are Betting On Cytokinetics, Incorporated (NASDAQ:CYTK) With A Big Upgrade This Week
May 07Financial Position Analysis
Short Term Liabilities: CYTK's short term assets ($1.1B) exceed its short term liabilities ($102.8M).
Long Term Liabilities: CYTK's short term assets ($1.1B) do not cover its long term liabilities ($1.3B).
Debt to Equity History and Analysis
Debt Level: CYTK has more cash than its total debt.
Reducing Debt: CYTK had negative shareholder equity 5 years ago, but is now positive and has therefore improved.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: CYTK has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if CYTK has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.